Gestation Dependant Changes in Angiogenic Factors and Their Associations with Fetal Growth Measures in Normotensive Pregnancy

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Sundrani, Deepali ^a   Khot, Vinita ^a   Pisal, Hemlata ^a   Mehendale, Savita ^b   Wagh, Girija ^b   Joshi, Asmita ^a   Joshi, Sadhana ^a  

^a Bharati Vidyapeeth Deemed University   (India)

^b Bharati Vidyapeeth's Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS MODULATOR; ANGIOGENIC FACTOR; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ARTICLE; BIRTH WEIGHT; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DELIVERY; DIASTOLIC BLOOD PRESSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS GROWTH; GESTATIONAL AGE; HUMAN; LONGITUDINAL STUDY; MATERNAL BLOOD; PREGNANCY; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UMBILICAL CORD BLOOD;

ADULT; BIRTH WEIGHT; BLOOD PRESSURE; FEMALE; FETAL BLOOD; FETAL DEVELOPMENT; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, SECOND; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84872222461     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054153     Document Type: Article

References (47)

1. Burton GJ, (2009) Oxygen, the Janus gas; its effects on human placental development and function. J Anat 215: 27e35.
2. Ferrara N, Gerber HP, Le Couter J, (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676.
3. Hicklin DJ, Ellis LM, (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23: 1011-1027.
4. Autiero M, Luttun A, Tjwa M, Carmeliet P, (2003) Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 1: 1356-1370.
5. Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, et al. (2003) Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9: 936-943.
6. Terman BI, Dougher VM, Carrion ME, Dimitrov D, Armellino DC, et al. (1992) Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187: 1579-1586.
7. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350: 672-683.
8. Kulkarni AV, Mehendale SS, Yadav HR, Kilari AS, Taralekar VS, et al. (2010) Circulating angiogenic factors and their association with birth outcomes in preeclampsia. Hypertens Res 33: 561-567.
9. Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, et al. (2007) Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 197: 244.e1-8.
10. Lygnos MC, Pappa KI, Papadaki HA, Relakis C, Koumantakis E, et al. (2006) Changes in maternal plasma levels of VEGF, bFGF, TGF-beta1, ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and gestational diabetes. In Vivo 20: 157-163.
11. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, et al. (2003) Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 188: 177-182.
12. Palm M, Basu S, Larsson A, Wernroth L, Åkerud H, et al. (2011) A longitudinal study of plasma levels of soluble fms-like tyrosine kinase 1 (sFlt1), placental growth factor (PlGF), sFlt1: PlGF ratio and vascular endothelial growth factor (VEGF-A) in normal pregnancy. Acta Obstet Gynecol Scand 90: 1244-1251.
13. Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, et al. (2004) First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 89: 770-775.
14. Romero R, Nien J, Espinoza J, Todem D, Fu W, et al. (2008) A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble VEGF receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small-for-gestational-age neonate. J Matern Fetal Neonatal Med 21: 9-23.
15. Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ, (2010) Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 122: 478-487.
16. Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, et al. (2007) Sequential changes in anti angiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 50: 137-142.
17. Ambrose JA, Barua RS, (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43: 1731-1737.
18. Mijal RS, Holzman CB, Rana S, Karumanchi SA, Wang J, et al. (2011) Mid pregnancy levels of angiogenic markers in relation to maternal characteristics. Am J Obstet Gynecol 204: 244.e1-12.
19. Giaccia AJ, Simon MC, Johnson R, (2004) The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease. Genes Dev 18: 2183-2194.
20. Patel J, Landers K, Mortimer RH, Richard K, (2010) Regulation of hypoxia inducible factors (HIF) in hypoxia and normoxia during placental development. Placenta 31: 951-957.
21. Boksa P, El-Khodor BF, (2003) Birth insult interacts with stress at adulthood to alter dopaminergic function in animal models: possible implications for schizophrenia and other disorders. Neurosci Biobehav Rev 27: 91-101.
22. Bulterys MG, Greenland S, Kraus JF, (1990) Chronic fetal hypoxia and suddeninfant death syndrome: interaction between maternal smoking and low hematocrit during pregnancy. Pediatrics 86: 535-540.
23. Ream M, Ray AM, Chandra R, Chikaraishi DM, (2008) Early fetal hypoxia leads to growth restriction and myocardial thinning. Am J Physiol Regul Integr Comp Physiol 295: R583-595.
24. Pugh CW, Ratcliffe PJ, (2003) Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 9: 677-684.
25. Kumar N, Gupta N, Kishore J, (2012) Kuppuswamy's socioeconomic scale: updating income ranges for the year 2012. Indian J Public Health 56: 103-104.
26. Kulkarni A, Mehendale S, Pisal H, Kilari A, Dangat K, et al. (2011) Association of omega-3 fatty acids and homocysteine concentrations in pre-eclampsia. Clin Nutr 30: 60-64.
27. Kalish RB, Thaler HT, Chasen ST, Gupta M, Berman SJ, et al. (2004) First- and second-trimester ultrasound assessment of gestational age. Am J Obstet Gynecol 191: 975-978.
28. Wills AK, Chinchwadkar MC, Joglekar CV, Natekar AS, Yajnik CS, et al. (2010) Maternal and paternal height and BMI and patterns of fetal growth: the Pune Maternal Nutrition Study. Early Hum Dev 86: 535-540.
29. Rao S, Yajnik CS, Kanade A, Fall CH, Margetts BM, et al. (2001) Intake of micronutrient-rich foods in rural Indian mothers is associated with the size of their babies at birth: Pune Maternal Nutrition Study. J Nutr 131: 1217-1224.
30. Yajnik CS, Deshpande SS, Jackson AA, Refsum H, Rao S, et al. (2008) Vitamin B12 and folate concentrations during pregnancy and insulin resistance in the offspring: the Pune Maternal Nutrition Study. Diabetologia 51: 29-38.
31. Adair TH, Gay WJ, Montani JP, (1990) Growth regulation of the vascular system: evidence for a metabolic hypothesis. Am J Physiol 259: R393-404.
32. Bdolah Y, Sukhatme VP, Karumanchi SA, (2004) Angiogenic imbalance in the pathophysiology of preeclampsia: newer insights. Semin Nephrol 24: 548-556.
33. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS, (2001) Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 184: 1267-1272.
34. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, et al. (2002) A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 187: 127-136.
35. Kaufmann P, Mayhew TM, Charnock-Jones DS, (2004) Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy. Placenta 25: 114-126.
36. Andraweera PH, Dekker GA, Roberts CT, (2012) The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update 18: 436-457.
37. Redman CW, Sargent IL, (2009) Placental stress and pre-eclampsia: a revised view. Placenta 30: S38-S42.
38. Bukhari SA, Rajoka MI, Ibrahim Z, Jalal F, Rana SM, et al. (2011) Oxidative stress elevated DNA damage and homocysteine level in normal pregnant women in a segment of Pakistani population. Mol Biol Rep 38: 2703-2710.
39. Mihailović M, Cvetković M, Ljubić A, Kosanović M, Nedeljković S, et al. (2000) Selenium and malondialdehyde content and glutathione peroxidase activity in maternal and umbilical cord blood and amniotic fluid. Biol Trace Elem Res 73: 47-54.
40. Ozkan Y, Yardim-Akaydin S, Erdem A, Simşek B, (2011) Variability of total thiol compounds, oxidative and nitrosative stress in uncomplicated pregnant women and nonpregnant women. Arch Gynecol Obstet 285: 1319-1324.
41. Ali KZ, Burton GJ, Khalid ME, Moosa R, Abd-Alla S, (2010) Concentrations of free vascular endothelial growth factor in the maternal and foetal circulations during pregnancy: a cross-sectional study. J Matern Fetal Neonatal Med 23: 1244-1248.
42. Ross B, McIntosh M, Rodaros D, Hébert TE, Rohlicek CV, (2010) Systemic arterial pressure at maturity in rats following chronic hypoxia in early life. Am J Hypertens 23: 1228-1233.
43. Tal R, Shaish A, Barshack I, Polak-Charcon S, Afek A, et al. (2010) Effects of hypoxia-inducible factor-1alpha over expression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction. Am J Pathol 177: 2950-2962.
44. Khong TY, De Wolf F, Robertson WB, Brosens I, (1986) Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 93: 1049e59.
45. Mayhew TM, Charnock-Jones DS, Kaufmann P, (2004) Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 25: 127e39.
46. Kim YM, Bujold E, Chaiworapongsa T, Gomez R, Yoon BH, et al. (2003) Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 189: 1063e9.
47. Kim YM, Chaiworapongsa T, Gomez R, Bujold E, Yoon BH, et al. (2002) Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 187: 1137e42.